Fulgent Genetics Inc (FLGT)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -42,708 -164,969 -163,428 -165,947 -168,334 -64,261 -49,811 -27,045 142,783 271,198 392,377 460,652 507,364 569,332 493,448 416,957 214,310 47,707 2,531 -459
Revenue (ttm) US$ in thousands 283,470 277,761 290,705 287,530 289,213 286,412 307,380 364,868 618,968 802,935 925,148 953,423 992,584 1,035,891 909,739 773,388 421,712 135,121 43,752 34,911
Net profit margin -15.07% -59.39% -56.22% -57.71% -58.20% -22.44% -16.21% -7.41% 23.07% 33.78% 42.41% 48.32% 51.12% 54.96% 54.24% 53.91% 50.82% 35.31% 5.78% -1.31%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-42,708K ÷ $283,470K
= -15.07%

Fulgent Genetics Inc's net profit margin has displayed significant fluctuations over the period analyzed. The company's net profit margin started at a negative level of -1.31% in March 2020 but showed improvement in the subsequent quarters, reaching a peak of 54.96% in September 2021.

However, the net profit margin began to decline after September 2021, dropping to 23.07% by December 2022. The trend of declining profitability continued into the next periods, with the net profit margin turning negative in March 2023 and reaching a low of -59.39% by September 2024.

The wide variation in net profit margin indicates inconsistent profitability for Fulgent Genetics Inc during the period. Investors and stakeholders may need to closely monitor the company's financial performance and evaluate the factors influencing its bottom line to assess the sustainability of its profitability levels.